שווי מתואם לחוב ומזומנים Sutro Biopharma, Inc. (STRO)

Sutro Biopharma, Inc. (STRO) is implementing unique cell-free synthesis for the rapid design of precise anti-tumor molecules. The share price history shows a current value of 232.57. Business growth is driven by the demand for targeted therapy and partnerships with global corporations. Sustainable development is guaranteed by a team of leading protein engineers dedicated to the company's innovative scientific research.

Sutro Biopharma, Inc. (STRO) is developing a unique protein synthesis platform to create affordable anti-cancer drugs. Enterprise Value (EV) combines market capitalization with debt, subtracting available cash. This algorithm determines the actual volume of investment required for a full buyout of the business. The metric allows for an assessment of how much the market currently prices in the potential for production scalability. The Enterprise Value (EV) trend reflects the balance between asset value and financial risks.